483 Document: Havix Group Inc d/b/a Aavis Pharmaceuticals, Apr 19, 2022

On Apr 19, 2022, the FDA inspected Havix Group Inc d/b/a Aavis Pharmaceuticals's Hoschton site. Explore the inspectional observations.